Sucralfate Treatment for Stomach and Duodenal Ulcers
For treatment of duodenal ulcers, sucralfate should be administered at a dose of 1 g four times per day on an empty stomach for 4-8 weeks, while gastric ulcers may require the same dosing regimen but with potentially lower healing rates. 1
Recommended Dosage Regimens
Active Ulcer Treatment
- For active duodenal ulcers, the FDA-approved dosage is 1 g four times daily on an empty stomach, continuing for 4-8 weeks unless healing has been demonstrated by x-ray or endoscopic examination 1
- Antacids may be prescribed for pain relief but should not be taken within 30 minutes before or after sucralfate 1
- Sucralfate works by binding to proteinaceous material at the ulcer site, forming a protective barrier against acid, pepsin, and bile salts 2
- Healing may begin during the first 1-2 weeks of treatment, but the full 4-8 week course is recommended to ensure complete healing 1
Maintenance Therapy
- For maintenance therapy after ulcer healing, the recommended dosage is 1 g twice daily 1
- Maintenance therapy with sucralfate 1 g twice daily has been shown to reduce duodenal ulcer relapse rates from approximately 60% to 20% after 6 months, and from 81% to about 30% after one year 3
Clinical Efficacy and Positioning
- Proton pump inhibitors (PPIs) are generally considered first-line agents for treating and preventing gastrointestinal ulcers, with sucralfate recommended as a second-line agent 4, 5
- For H. pylori-associated ulcers, eradication therapy should be used in addition to sucralfate 4, 6
- In comparative studies, sucralfate 1 g four times daily has shown healing rates comparable to cimetidine and ranitidine for duodenal ulcers (75-97.6% after 4-8 weeks) 7
- Gastric ulcer healing rates with sucralfate tend to be lower than for duodenal ulcers, but are still comparable to those achieved with H2-receptor antagonists 8
Special Patient Populations
- In elderly patients, dose selection should be cautious, usually starting at the lower end of the dosing range, due to potential decreased hepatic, renal, or cardiac function 1
- For critically ill patients requiring stress ulcer prophylaxis, PPIs or H2-receptor antagonists are typically preferred over sucralfate 4, 5
- For NSAID-induced ulcers, discontinuation of NSAIDs is recommended when possible; if NSAIDs must be continued, PPIs are preferred for gastroprotection 4, 6
Safety Profile and Administration Considerations
- Sucralfate has minimal systemic absorption (3-5%), with more than 90% excreted unchanged in feces, resulting in few systemic side effects 2
- The most common side effect is constipation (2-4%), with xerostomia (1%) and skin eruptions (0.6%) reported less frequently 2, 8
- Sucralfate should be taken on an empty stomach, typically 1 hour before meals and at bedtime 1, 2
- No significant drug-drug interactions have been reported, but sucralfate should not be taken within 30 minutes of antacids 1, 2
Alternative Dosing Regimens
- Some studies suggest that 2 g twice daily may be as effective as the conventional 1 g four times daily regimen for duodenal ulcer healing 3
- For maintenance therapy to prevent gastric ulcer relapse, a regimen of 1 g in the morning and 2 g at night has shown efficacy 3
- Recent evidence suggests that a single nocturnal dose of 2 g may offer effective maintenance therapy for both duodenal and gastric ulcers 3